No Data
No Data
Bide Pharmatech Investing $103 Million in Zhuhai Vivo Investment JV
After the Recent Decline, Bide Pharmatech Co., Ltd. (SHSE:688073) CEO Lan Dai's Holdings Have Lost 8.6% of Their Value
These 4 Measures Indicate That Bide Pharmatech (SHSE:688073) Is Using Debt Reasonably Well
Bide Pharmatech Co., Ltd.'s (SHSE:688073) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Bide Pharmatech Co., Ltd.'s (SHSE:688073) Market Cap Increased by CN¥589m, Insiders Receive a 48% Cut
Are Bide Pharmatech Co., Ltd.'s (SHSE:688073) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
No Data